Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Positive and Negative Regulation by NK Cells in Cancer

Volume 19, Issue 1-2, 2014, pp. 57-66
DOI: 10.1615/CritRevOncog.2014010805
Get accessGet access

ABSTRACT

Our understanding of NK biology has expanded immensely since the initial discovery of natural killer cells in 1975. New studies have uncovered various levels of immune regulation both on and by unique subsets of NK cells, which go well beyond simple receptor−ligand interactions between NK cells and target cancer cells. Distinct suppressor and effector populations of NK cells have been delineated in both viral and tumor models. Interactions between NK cells and dendritic cells, T cells, and B cells also dramatically alter the overall immune response to cancer. To exploit the diverse functional abilities of NK cell subsets for cancer immunotherapies, it is important to understand NK cell biology and NK regulator mechanisms.

CITED BY
  1. Verma Chandan, Kaewkangsadan Viriya, Eremin Jennifer M, Cowley Gerard P, Ilyas Mohammad, El-Sheemy Mohamed A, Eremin Oleg, Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery, Journal of Translational Medicine, 13, 1, 2015. Crossref

  2. Wang YaJie, Chen Chen, Dong Fang, Ma ShiHui, Xu Jing, Gong YueMin, Cheng Hui, Zhou Yuan, Cheng Tao, Hao Sha, NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions, Science China Life Sciences, 58, 12, 2015. Crossref

  3. Muenst S., Läubli H., Soysal S. D., Zippelius A., Tzankov A., Hoeller S., The immune system and cancer evasion strategies: therapeutic concepts, Journal of Internal Medicine, 279, 6, 2016. Crossref

  4. Guillerey Camille, Huntington Nicholas D, Smyth Mark J, Targeting natural killer cells in cancer immunotherapy, Nature Immunology, 17, 9, 2016. Crossref

  5. Fang Fang, Xiao Weihua, Tian Zhigang, NK cell-based immunotherapy for cancer, Seminars in Immunology, 31, 2017. Crossref

  6. Sterle Helena A., Nicoud Melisa B., Massari Noelia A., Táquez Delgado Mónica A., Herrero Ducloux María V., Cremaschi Graciela A., Medina Vanina A., Immunomodulatory role of histamine H4 receptor in breast cancer, British Journal of Cancer, 120, 1, 2019. Crossref

  7. Calmeiro João, Carrascal Mylene, Gomes Célia, Falcão Amílcar, Cruz Maria Teresa, Neves Bruno Miguel, Highlighting the Role of DC-NK Cell Interplay in Immunobiology and Immunotherapy, in Dendritic Cells, 2018. Crossref

  8. Reijmen Eva, Vannucci Luca, De Couck Marijke, De Grève Jacques, Gidron Yori, Therapeutic potential of the vagus nerve in cancer, Immunology Letters, 202, 2018. Crossref

  9. Rodriguez Galaxia, Galpin Kristianne, McCloskey Curtis, Vanderhyden Barbara, The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy, Cancers, 10, 8, 2018. Crossref

  10. Bruno Antonino, Bassani Barbara, D'Urso Davide Giuseppe, Pitaku Ilvana, Cassinotti Elisa, Pelosi Giuseppe, Boni Luigi, Dominioni Lorenzo, Noonan Douglas M., Mortara Lorenzo, Albini Adriana, Angiogenin and the MMP9‐TIMP2 axis are up‐regulated in proangiogenic, decidual NK‐like cells from patients with colorectal cancer, The FASEB Journal, 32, 10, 2018. Crossref

  11. Mace Thomas A., Ware Michael B., King Samantha A., Loftus Shannon, Farren Matthew R., McMichael Elizabeth, Scoville Steven, Geraghty Connor, Young Gregory, Carson William E., Clinton Steven K., Lesinski Gregory B., Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function, Scientific Reports, 9, 1, 2019. Crossref

  12. Kabiljo Julijan, Harpain Felix, Carotta Sebastian, Bergmann Michael, Radiotherapy as a Backbone for Novel Concepts in Cancer Immunotherapy, Cancers, 12, 1, 2019. Crossref

  13. Jaiswara Pradip Kumar, Gupta Vishal Kumar, Rawat Shiv Govind, Sonker Pratishtha, Kumar Ajay, Reprogramming of Tumor Associated Immune Cells by Phytochemicals: In-vitro Approaches for Cancer Treatment, in Phytochemistry: An in-silico and in-vitro Update, 2019. Crossref

  14. Han Chen, Jiang Yongjie, Wang Zhaoxia, Wang Hengxiao, Natural killer cells involved in tumour immune escape of hepatocellular carcinomar, International Immunopharmacology, 73, 2019. Crossref

  15. Piñeiro Fernández Julián, Luddy Kimberly A., Harmon Cathal, O’Farrelly Cliona, Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function, International Journal of Molecular Sciences, 20, 17, 2019. Crossref

  16. Gall Margaret G., Zhang Hui Emma, Lee Quintin, Jolly Christopher J., McCaughan Geoffrey W., Cook Adam, Roediger Ben, Gorrell Mark D., Immune regeneration in irradiated mice is not impaired by the absence of DPP9 enzymatic activity, Scientific Reports, 9, 1, 2019. Crossref

  17. Gingrich Alicia A., Modiano Jaime F., Canter Robert J., Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy, Journal of Clinical Medicine, 8, 11, 2019. Crossref

  18. McNerney Kevin O., Karageorgos Spyridon A., Hogarty Michael D., Bassiri Hamid, Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells, Frontiers in Immunology, 11, 2020. Crossref

  19. Galli Filippo, Aguilera Jesus Vera, Palermo Belinda, Markovic Svetomir N., Nisticò Paola, Signore Alberto, Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy, Journal of Experimental & Clinical Cancer Research, 39, 1, 2020. Crossref

  20. Apraiz Aintzane, Benedicto Aitor, Marquez Joana, Agüera-Lorente Andrea, Asumendi Aintzane, Olaso Elvira, Arteta Beatriz, Innate Lymphoid Cells in the Malignant Melanoma Microenvironment, Cancers, 12, 11, 2020. Crossref

  21. Antohe Mihaela, Nedelcu Roxana, Nichita Luciana, Popp Cristiana, Cioplea Mirela, Brinzea Alice, Hodorogea Anastasia, Calinescu Andreea, Balaban Mihaela, Ion Daniela, Diaconu Carmen, Bleotu Coralia, Pirici Daniel, Zurac Sabina, Turcu Gabriela, Tumor infiltrating lymphocytes: The regulator of melanoma evolution (Review), Oncology Letters, 2019. Crossref

  22. Englinger Bernhard, Pirker Christine, Heffeter Petra, Terenzi Alessio, Kowol Christian R., Keppler Bernhard K., Berger Walter, Metal Drugs and the Anticancer Immune Response, Chemical Reviews, 119, 2, 2019. Crossref

  23. Sorrentino Carlo, D’Antonio Luigi, Fieni Cristiano, Ciummo Stefania Livia, Di Carlo Emma, Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival, Frontiers in Immunology, 12, 2021. Crossref

  24. Wu Ming, Wang Sheng, Chen Jian-Yu, Zhou Li-Juan, Guo Zi-Wen, Li Yu-Hua, Therapeutic cancer vaccine therapy for acute myeloid leukemia, Immunotherapy, 13, 10, 2021. Crossref

  25. Saadey Abbey A., Yousif Amir, Ghoneim Hazem E., Epigenetic programming of the immune responses in cancer, in Cancer Immunology and Immunotherapy, 2022. Crossref

  26. Aguilar Ethan G., Dunai Cordelia, Judge Sean J., Zamora Anthony E., Khuat Lam T., Vick Logan V., Collins Craig P., Stoffel Kevin M., Alvarez Maite, Barao Isabel, Miller Jeffrey S., Blazar Bruce R., Chevallier Patrice, Retiere Christelle, Canter Robert J., Murphy William J., Activation status dictates the function of unlicensed natural killer cells in mice and humans, Blood Advances, 5, 20, 2021. Crossref

  27. Fares Jawad, Gupta Sumit, Gopalakrishnan Vidya, Khatua Soumen, NK cells in brain tumors: From biology to treatment, in Successes and Challenges of NK Immunotherapy, 2021. Crossref

  28. Moyal Leah, Navasardyan Inesa, Bonavida Benjamin, New therapeutic modalities in breast cancer by targeting NK cell inhibitory and activating receptors, in Successes and Challenges of NK Immunotherapy, 2021. Crossref

  29. Allison Michaela, Mathews Joel, Gilliland Taylor, Mathew Stephen O., Natural Killer Cell-Mediated Immunotherapy for Leukemia, Cancers, 14, 3, 2022. Crossref

  30. Stephen Zachary R., Zhang Miqin, Recent Progress in the Synergistic Combination of Nanoparticle‐Mediated Hyperthermia and Immunotherapy for Treatment of Cancer, Advanced Healthcare Materials, 10, 2, 2021. Crossref

  31. Venglar Ondrej, Bago Julio Rodriguez, Motais Benjamin, Hajek Roman, Jelinek Tomas, Natural Killer Cells in the Malignant Niche of Multiple Myeloma, Frontiers in Immunology, 12, 2022. Crossref

  32. Rossi Fiorella, Fredericks Nathaniel, Snowden Andrew, Allegrezza Michael J., Moreno-Nieves Uriel Y., Next Generation Natural Killer Cells for Cancer Immunotherapy, Frontiers in Immunology, 13, 2022. Crossref

  33. Lorenzo-Anota Helen Y., Martínez-Loria Alan B., Tamez-Guerra Reyes S., Scott-Algara Daniel, Martínez-Torres Ana C., Rodríguez-Padilla Cristina, Changes in the natural killer cell repertoire and function induced by the cancer immune adjuvant candidate IMMUNEPOTENT-CRP, Cellular Immunology, 374, 2022. Crossref

  34. Kim Hei Jung, Ji Young Rae, Lee You Mie, Crosstalk between angiogenesis and immune regulation in the tumor microenvironment, Archives of Pharmacal Research, 45, 6, 2022. Crossref

  35. Almeida-Nunes Diana Luísa, Mendes-Frias Ana, Silvestre Ricardo, Dinis-Oliveira Ricardo Jorge, Ricardo Sara, Immune Tumor Microenvironment in Ovarian Cancer Ascites, International Journal of Molecular Sciences, 23, 18, 2022. Crossref

  36. Sharrock Jessica, Natural Killer Cells and Their Role in Immunity, EMJ Allergy & Immunology, 2019. Crossref

  37. Flores Bianca C. T., Chawla Smriti, Ma Ning, Sanada Chad, Kujur Praveen Kumar, Yeung Rudy, Bellon Margot B., Hukari Kyle, Fowler Brian, Lynch Mark, Chinen Ludmilla T. D., Ramalingam Naveen, Sengupta Debarka, Jeffrey Stefanie S., Microfluidic live tracking and transcriptomics of cancer-immune cell doublets link intercellular proximity and gene regulation, Communications Biology, 5, 1, 2022. Crossref

  38. Lu Yihua, Xiao J., He Y., Natural Killer (NK) cells in immunotherapy and perspectives in antitumour approaches, BIO Web of Conferences, 55, 2022. Crossref

  39. Moya Leire, Farashi Samaneh, Suravajhala Prashanth, Janaththani Panchadsaram, Batra Jyotsna, Severe COVID-19 May Impact Hepatic Fibrosis /Hepatic Stellate Cells Activation as Indicated by a Pathway and Population Genetic Study, Genes, 14, 1, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain